GE HealthCare price target raised to $105 from $90 at Redburn Atlantic

Redburn Atlantic raised the firm’s price target on GE HealthCare to $105 from $90 and keeps a Buy rating on the shares. GE HealthCare is a leading healthcare equipment provider that can benefit from the growing demand for diagnostic services and precision treatment, enhanced workflow solutions and patient monitoring, the analyst tells investors in a research note. The firm says the company is well positioned to achieve its medium-term revenue guidance of mid-single-digit organic growth, supported by strong fundamental demand for imaging and accelerating demand for radiopharmaceutical diagnostics, where it is a market leader.